Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Meanwhile AKRO.....a 2B$ company

<< Previous

Bullboard Posts

Next >>

Comment by Biobobon Oct 07, 2022 9:06am

85 Views

Post# 35011824

RE:Meanwhile AKRO.....a 2B$ company

No short term gain with Th1902 = Accountibility. It's payback time whatever excuse the find in case of lack of improvement in the stock price. They must be reminded that whatever their personal endevours are that we are the reason of their existance.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"